BTS
GILD icon

BB&T Securities’s Gilead Sciences GILD Stock Holding History

BB&T Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-12,300
Closed -$1.02M – 1050
2014
Q2 		$1.02M Hold
12,300
– – 0.02% 453
2014
Q1 		$872K Buy
+12,300
New +$965K 0.02% 450

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BB&T Securities's GILD Position: Q3 2019 in Review

BB&T Securities increased its Gilead Sciences (GILD) stake by 43% in Q3 2019, buying an estimated $7.2M and bringing the position to 365,818 shares worth $23.1M. The position accounts for 0.21% of the portfolio, ranked #123.

BB&T Securities first reported a position in GILD in Q2 2013 and has held it in 26 quarters since. The position peaked at $57.1M in Q4 2016. 1,464 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • BB&T Securities held 365,818 shares of Gilead Sciences worth $23.1M as of Q3 2019.
  • BB&T Securities bought 110,113 Gilead Sciences shares in Q3 2019, an estimated $7.2M.
  • Gilead Sciences made up 0.21% of BB&T Securities's portfolio in Q3 2019, its #123 holding.
  • BB&T Securities first reported a position in Gilead Sciences in Q2 2013 and has held it in 26 quarters since.
  • BB&T Securities's Gilead Sciences position peaked at $57.1M in Q4 2016.
  • 1,464 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.